Leukemia & Lymphoma, 1029-2403

Journal

More filtering options
  1. 2019
  2. Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

    Delsing Malmberg, E., Johansson Alm, S., Nicklasson, M., Lazarevic, V., Ståhlman, S., Samuelsson, T., Lenhoff, S., Asp, J., Mats Ehinger, Palmqvist, L., Brune, M. & Fogelstrand, L., 2019, In : Leukemia and Lymphoma. 60, 2, p. 409-417

    Research output: Contribution to journalArticle

  3. 2018
  4. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations

    Dreyling, M., Aurer, I., Cortelazzo, S., Hermine, O., Hess, G., Mats Jerkeman, Le Gouill, S., Ribrag, V., Trněný, M., Visco, C., Walewski, J., Zaja, F. & Zinzani, P. L., 2018, In : Leukemia and Lymphoma. 59, 8, p. 1814-1828

    Research output: Contribution to journalArticle

  5. 2017
  6. Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study

    Henrik Cederleuf, Hjort Jakobsen, L., Fredrik Ellin, de Nully Brown, P., Stauffer Larsen, T., Bøgsted, M., Relander, T., Mats Jerkeman & El-Galaly, T. C., 2017 Dec 2, In : Leukemia and Lymphoma. 58, 12, p. 2815-2823 9 p.

    Research output: Contribution to journalArticle

  7. Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

    Hasni, M. S., Berglund, M., Yakimchuk, K., Guan, J., Linderoth, J., Amini, R-M., Enblad, G. & Okret, S., 2017 Feb 1, In : Leukemia & Lymphoma. 58, 2, p. 418-427 10 p.

    Research output: Contribution to journalArticle

  8. Frequency and clinical implications of SOX11 expression in Burkitt lymphoma

    Tove Wästerlid, Nordström, L., Freiburghaus, C., Pedersen, M., Nørgaard, P., Gang, A. O., Brown, P., Michael Dictor, Mats Jerkeman & Sara Ek, 2017, In : Leukemia & Lymphoma. 58, 7, p. 1760-1763 4 p.

    Research output: Contribution to journalLetter

  9. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

    Hess, G., Rule, S., Jurczak, W., Mats Jerkeman, Santucci Silva, R., Rusconi, C., Caballero, D., Joao, C., Witzens-Harig, M., Bence-Bruckler, I., Cho, S-G., Zhou, W., Goldberg, J. D., Trambitas, C., Enny, C., Vermeulen, J., Traina, S., Chiou, C. F., Diels, J. & Dreyling, M., 2017, In : Leukemia and Lymphoma. 58, 12, p. 2824-2832

    Research output: Contribution to journalArticle

  10. Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia

    Yektaei-Karin, E., Zovko, A., Nilsson, A., Näsman-Glaser, B., Kanter, L., Rådmark, O., Wallvik, J., Marja Ekblom, Dolinska, M., Qian, H. & Stenke, L., 2017, In : Leukemia & Lymphoma. 58, 8, p. 1903-1913 11 p.

    Research output: Contribution to journalArticle

  11. 2016
  12. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia

    Ivanov Öfverholm, I., Tran, A. N., Linda Olsson, Zachariadis, V., Heyman, M., Rudd, E., Syk Lundberg, E., Nordenskjöld, M., Bertil Johansson, Nordgren, A. & Barbany, G., 2016, In : Leukemia & Lymphoma. 57, 9, p. 2161-2170 10 p.

    Research output: Contribution to journalArticle

  13. Single nucleotide polymorphism array analysis of clonal evolution in younger adult acute lymphoblastic leukemia

    Dirse, V., Gineikiene, E., Zvirblis, T., Bertasiute, R., Kajsa Paulsson & Griskevicius, L., 2016, In : Leukemia & Lymphoma. 57, 11, p. 2716-2719 4 p.

    Research output: Contribution to journalArticle

  14. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.

    Venera Kuci, Nordström, L., Conrotto, P. & Sara Ek, 2016, In : Leukemia & Lymphoma.

    Research output: Contribution to journalArticle

  15. 2015
  16. F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

    Mylam, K. J., Kostakoglu, L., Hutchings, M., Coleman, M., Lamonica, D., Czuczman, M. S., Diehl, L. F., Nielsen, A. L., Jensen, P., Loft, A., Hendel, H. W., Iyer, V., Leppa, S., Jyrkkio, S., Holte, H., Eriksson, M., Gillstrom, D., Hansen, P. B., Seppanen, M., Hjorthaug, K. & 2 othersBrown, P. D. N. & Pedersen, L. M., 2015, In : Leukemia & Lymphoma. 56, 7, p. 2005-2012

    Research output: Contribution to journalArticle

  17. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries

    Koljonen, V., Rantanen, M., Sahi, H., Mellemkjaer, L., Hansen, B. T., Chen, T., Kari Hemminki & Pukkala, E., 2015, In : Leukemia & Lymphoma. 56, 12, p. 3315-3319

    Research output: Contribution to journalArticle

  18. Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

    Ohm, L., Lundqvist, A., Dickman, P., Hoglund, M., Persson, U., Stenke, L., Carlsson, K. S. & Bjorkholm, M., 2015, In : Leukemia & Lymphoma. 56, 5, p. 1385-1391

    Research output: Contribution to journalArticle

  19. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network

    Dreyling, M., Amador, V., Callanan, M., Mats Jerkeman, Le Goui, S., Pott, C., Rule, S. & Zaja, F., 2015, In : Leukemia & Lymphoma. 56, 4, p. 866-876

    Research output: Contribution to journalReview article

  20. 2014
  21. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas

    Högfeldt, T., Johnsson, P., Grandér, D., Bahnassy, A. A., Anna Porwit, Eid, S., Österborg, A., Zekri, A. R. N., Lundahl, J., Khaled, M. H., Mellstedt, H. & Moshfegh, A., 2014 Jan 1, In : Leukemia and Lymphoma. 55, 5, p. 1158-1165

    Research output: Contribution to journalArticle

  22. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic

    Mulligan, S. P., Karlsson, K., Stromberg, M., Jonsson, V., Gill, D., Hammerstrom, J., Hertzberg, M., McLennan, R., Uggla, B., Norman, J., Wallvik, J., Sundstrom, G., Johansson, H., Brandberg, Y., Liliemark, J. & Gunnar Juliusson, 2014, In : Leukemia & Lymphoma. 55, 12, p. 2769-2777

    Research output: Contribution to journalArticle

  23. 2013
  24. Protein kinase C expression is deregulated in chronic lymphocytic leukemia

    Kabir, N. N., Lars Rönnstrand & Julhash U. Kazi, 2013, In : Leukemia & Lymphoma. 54, 10, p. 2288-2290

    Research output: Contribution to journalLetter

  25. 2012
  26. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

    Machaczka, M., Johansson, J-E., Remberger, M., Hallbook, H., Malm, C., Lazarevic, V., Wahlin, A., Omar, H., Gunnar Juliusson, Kimby, E. & Hagglund, H., 2012, In : Leukemia & Lymphoma. 53, 9, p. 1699-1705

    Research output: Contribution to journalArticle

  27. Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study

    Lazarevic, V., Remberger, M., Hagglund, H., Gunnar Juliusson, Omar, H., Halbook, H., Kimby, E., Malm, C., Wahlin, A. & Johansson, J-E., 2012, In : Leukemia & Lymphoma. 53, 3, p. 503-505

    Research output: Contribution to journalLetter

  28. MyelomA Genetics International Consortium

    Morgan, G., Johnsen, H. E., Goldschmidt, H., Palumbo, A., Cavo, M., Sonneveld, P., San Miguel, J., Chim, C. S., Browne, P., Einsele, H., Waage, A., Ingemar Turesson, Spencer, A., Hajek, R., Ludwig, H., Hemminki, K. & Houlston, R., 2012, In : Leukemia & Lymphoma. 53, 5, p. 796-800

    Research output: Contribution to journalReview article

  29. 2011
  30. Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy.

    Gunnar Juliusson & Samuelsson, H., 2011, In : Leukemia & Lymphoma. 52 Suppl 2, p. 46-49

    Research output: Contribution to journalArticle

  31. 'Hairy' cells: where are the roots of this leukemia?

    Gunnar Juliusson, Tadmor, T. & Polliack, A., 2011, In : Leukemia & Lymphoma. 52, p. 2205-2206

    Research output: Contribution to journalArticle

Previous 1 2 Next